In 2025, Omada Insights Labs ANSWERS Initiative set out to understand how GLP-1s drive outcomes in real-world settings, recognizing that insights drawn from clinical trials, while invaluable, often reflect idealized conditions that don't capture the complexities of everyday life
LZ: Funding acquisition, Supervision, Validation, Writing review and editing
For investors, this balance is telling
Veremiychuk, Russian Journal of Physiotherapy, Balneology and Rehabilitation.2025
For many Lipedema patients, GLP-1s are used at lower doses and with very specific goals
they are being studied as metabolic medications that may affect outcomes in hormone-sensitive disease